Amrutanjan Health Care Limited | AMRUTANJAN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
2,5322,6153,3284,2123,942
Cost of revenue
Cost of revenue
-1,189-1,171-1,402-1,805-1,820
Gross Profit
Gross Profit
1,344
1,444
1,927
2,408
2,122
Sales, general & ad...
Sales, general and administrative
-1,031-1,137-719-1,459-1,533
Depreciation
Depreciation and amortization
-32-44-37-38-52
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00-46000
Operating income
Operating income EBIT
281
264
711
911
537
 
      
Profit before tax
Profit before tax
352345819906536
Net Income
Net income
245
251
612
672
398
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
8.39
8.58
20.93
23.00
13.65